Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In-vitro testing of cyclophosphamide on tumors.

× No keyword cloud information.

6 in total

1. [ON THE ACTIVATION OF CYCLOPHOSPHAMIDE IN VIVO AND IN VITRO].

Authors: N BROCK; H J HOHORST
Journal: Arzneimittelforschung Date: 1963-12

2. Studies on the mechanism of action of cytoxan. Evidence of activation in vivo and in vitro.

Authors: G E FOLEY; O M FRIEDMAN; B P DROLET
Journal: Cancer Res Date: 1961-01 Impact factor: 12.701

3. Sensitivity tests of tumors to cytostatic agents. I. Comparative investigations on transplanted tumors in vivo and in vitro.

Authors: M Volm; M Faufmann; J MAttern; K Wayss
Journal: Z Krebsforsch Klin Onkol Cancer Res Clin Oncol Date: 1975

4. [Possibilities and limits of pre-therapeutic neoplasm sensitivity cytostatics tests under short-term conditions].

Authors: M Volm; M Kaufmann; J Mattern; K Wayss
Journal: Schweiz Med Wochenschr Date: 1975-01-18

5. [The effect of cyclophosphamide on tumors in the sensitivity-test (author's transl)].

Authors: M Kaufmann; J Mattern; K Wayss; M Volm
Journal: Arch Gynakol Date: 1975

6. [Studies on the spontaneous decomposition of 4-hydroxyphosphamide and 4-hydroperoxyphosphamide by means of thin-layer chromatography].

Authors: G Völker; U Dräger; G Peter; H J Hohorst
Journal: Arzneimittelforschung Date: 1974-08

6 in total

4 in total

1. Suppression of in vitro peripheral blood lymphocyte mitogenesis by cytotoxic drugs commonly used in the treatment of breast cancer: a comparative study.

Authors: M Gereis; A P Burford-Mason; S M Watkins
Journal: Agents Actions Date: 1987-12

2. Detection of induced tumour-resistance to cyclophosphamide by the in vitro short term test.

Authors: M Volm; J Mattern; K Wayss
Journal: Arch Gynakol Date: 1977-11-29

3. Influence of low-dose beta-interferon on natural killer cell activity in breast cancer patients subjected to chemotherapy.

Authors: L Tentori; M P Fuggetta; S D'Atri; A Aquino; C Nunziata; M Roselli; P Ballatore; E Bonmassar; L De Vecchis
Journal: Cancer Immunol Immunother Date: 1987 Impact factor: 6.968

4. The natural compound forskolin synergizes with dexamethasone to induce cell death in myeloma cells via BIM.

Authors: Virginie Follin-Arbelet; Kristine Misund; Elin Hallan Naderi; Hege Ugland; Anders Sundan; Heidi Kiil Blomhoff
Journal: Sci Rep Date: 2015-08-26 Impact factor: 4.379

4 in total